We serve Chemical Name:4-Cyanobiphenyl CAS:2920-38-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:4-Cyanobiphenyl
CAS.NO:2920-38-9
Synonyms:4-Phenylbenzonitrile;p-Cyanobiphenyl;4-phenylbenzylnitrile;Biphenyl-4-carbonitril;MFCD00001821;4-phenyl-benzonitrile;[1, 1′-Biphenyl]-4-carbonitrile;biphenylnitrile;biphenyl-4-carbonitrile;p-NC-C6H4-Ph;(1,1′-Biphenyl)-4-carbonitrile;[1,1′-Biphenyl]-4-carbonitrile;EINECS 220-860-2;4-Cyanodiphenyl;4-Cyanobiphenyl;4-Biphenylcarboxylic acid nitrile;4-CN-C6H4-Ph;NCR DR;4-Biphenylcarbonitrile;p-Phenylbenzonitrile;4-phenylbenzenecarbonitrile
Molecular Formula:C13H9N
Molecular Weight:179.217
HS Code:2926909090
Physical and Chemical Properties:
Melting point:85-87 °C(lit.)
Boiling point:332.3±21.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.616
PSA:23.79000
Exact Mass:179.073502
LogP:3.29
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:UN 3439 6.1/PG 3
Packing Group:III
Contact us for information like 4-Phenylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-phenylbenzenecarbonitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Biphenyl-4-carbonitril Use and application,biphenylnitrile technical grade,usp/ep/jp grade.
Related News: Zynteglo was granted conditional marketing authorisation in May 2019. The conditional authorisation means that there is more evidence to come about the medicine, which the company will provide. EMA regularly reviews new information that becomes available. (R)-5-(azidomethyl)-3-(4-(trifluoromethoxy)phenyl)-4,5-dihydroisoxazole manufacturers It’s official. Nearly two years after the FDA granted conditional approval to Merck’s Keytruda and Eisai’s Lenvima for endometrial cancer, the U.S. regulator has blessed the combination therapy, with no strings attached. N1-(3,4-difluorophenylmethyl)-N1-(4-cyanophenyl)hydrazine suppliers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 2,2-Dimethyl-propionic acid (2S,3R)-7-benzyloxy-2,3-dihydroxy-heptyl ester vendor & factory.
